TNGX
Tango Therapeutics Inc.
$8.11
+$0.14(+1.76%)
55
Overall
60
Value
50
Tech
--
Quality
Market Cap
$866.72M
Volume
2.59M
52W Range
$1.03 - $9.70
Target Price
$11.63
Order:
Income Statement
| Metric | Trend | Chart | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|
| REVENUE | |||||||
| Total Revenue | $7.7M | $37.0M | $24.9M | $36.5M | $42.1M | ||
| Total Revenue | $7.7M | $37.0M | $24.9M | $36.5M | $42.1M | ||
| GROSS PROFIT | |||||||
| Gross Profit | $7.7M | $37.0M | $24.9M | $36.5M | $42.1M | ||
| OPERATING EXPENSES | |||||||
| Operating Expenses | $59.9M | $95.2M | $135.9M | $150.7M | $187.7M | ||
| Research & Development | $50.0M | $77.6M | $105.9M | $115.2M | $143.9M | ||
| Research Expense | $50.0M | $77.6M | $105.9M | $115.2M | $143.9M | ||
| Selling, General & Administrative | $9.9M | $17.6M | $30.0M | $35.5M | $43.7M | ||
| Selling & Marketing Expenses | $40.0K | -- | -- | -- | -- | ||
| General & Administrative Expenses | $9.9M | $17.6M | $30.0M | $35.5M | $43.7M | ||
| Salaries & Wages | $32.6K | -- | $14.2M | $19.1M | $28.9M | ||
| Depreciation & Amortization | $700.0K | $900.0K | $1.6M | $2.4M | $2.5M | ||
| Depreciation & Amortization | $700.0K | $900.0K | $1.6M | $2.4M | $2.5M | ||
| Other Operating Expenses | $2.6M | $2.7M | $4.5M | $7.9M | $8.0M | ||
| OPERATING INCOME | |||||||
| Operating income | $-52.2M | $-58.2M | $-111.1M | $-114.2M | $-145.6M | ||
| EBITDA | $-51.5M | $-57.3M | $-105.6M | $-102.2M | $-131.7M | ||
| NON-OPERATING ITEMS | |||||||
| Interest Expense (Non-Operating) | $-108.0K | $-495.0K | $-1.5M | $-6.6M | $-7.9M | ||
| Intinc | $65.2K | -- | -- | -- | -- | ||
| Net Non-Operating Interest Income/Expense | $108.0K | $495.0K | $1.5M | $6.6M | $7.9M | ||
| Other Income/Expense | $-127.0K | $1.0M | $1.5M | $-9.8M | $-7.8M | ||
| Other Special Charges | $120.0K | $-248.0K | $1.5M | $5.9M | $7.6M | ||
| PRE-TAX INCOME | |||||||
| EBIT | $-52.2M | $-58.2M | $-109.6M | $-108.2M | $-138.0M | ||
| Pre-Tax Income | $-52.0M | $-57.9M | $-108.1M | $-101.6M | $-130.1M | ||
| INCOME TAX | |||||||
| Tax Provision | $6.9K | $292.0K | $54.0K | $134.0K | $208.0K | ||
| NET INCOME | |||||||
| Net Income | $-52.0M | $-58.2M | $-108.2M | $-101.7M | $-130.3M | ||
| Net Income (Continuing Operations) | $-52.0M | $-58.2M | $-108.2M | $-101.7M | $-130.3M | ||
| Net Income (Discontinued Operations) | $-52.0M | $-58.2M | $-108.2M | $-101.7M | $-130.3M | ||
| Net Income (Common Stockholders) | $-52.0M | $-58.2M | $-108.2M | $-101.7M | $-130.3M | ||
| Normalized Income | -- | -- | -- | -- | $-128.8M | ||
| TOTALS | |||||||
| Total Expenses | $59.9M | $95.2M | $135.9M | $150.7M | $187.7M | ||
| SHARE & EPS DATA | |||||||
| Average Shares Outstanding | $31.9M | $62.1M | $87.8M | $94.6M | $109.2M | ||
| Average Shares Outstanding (Diluted) | $31.9M | -- | $87.8M | $94.6M | $109.2M | ||
| Shares Outstanding | $21.4M | $87.7M | $88.2M | $106.7M | $108.1M | ||
| Basic EPS | $-1.63 | $-0.94 | $-1.23 | $-1.08 | $-1.19 | ||
| Basic EPS (Continuing Operations) | $-1.63 | $-0.94 | $-1.23 | $-1.08 | $-1.19 | ||
| Diluted EPS | $-1.63 | $-0.94 | $-1.23 | $-1.08 | $-1.19 | ||
| Diluted EPS (Continuing Operations) | -- | -- | $-1.23 | $-1.08 | $-1.19 | ||
| OTHER METRICS | |||||||
| Other Gand A | $9.9M | $17.6M | $30.0M | $35.5M | $43.7M | ||
| Rent And Landing Fees | $108.9K | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TNGX | $8.11 | +1.8% | 2.59M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |